已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The SPARC Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer

医学 膀胱切除术 膀胱癌 结果(博弈论) 泌尿科 前列腺癌 前列腺切除术 肿瘤科 内科学 癌症 数学 数理经济学
作者
Manuel S. Eisenberg,Stephen A. Boorjian,John C. Cheville,R. Houston Thompson,Prabin Thapa,Dharam Kaushik,Igor Frank
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:190 (6): 2005-2010 被引量:62
标识
DOI:10.1016/j.juro.2013.06.022
摘要

While multiple independent clinicopathological variables are associated with the outcome of radical cystectomy for bladder cancer, limited prediction tools exist to facilitate individualized risk assessment. We developed the SPARC (Survival Prediction After Radical Cystectomy) score, a prediction model for bladder cancer specific survival after radical cystectomy.We evaluated 2,403 patients who underwent radical cystectomy without neoadjuvant therapy at our institution between 1980 and 2008 with pathological re-review of all specimens. Of these patients 1,776 with nonmetastatic urothelial carcinoma were identified for analysis. A multivariate model was developed using stepwise selection to determine variables associated with cancer specific survival. We created a scoring system based on the β coefficients of this model.Median followup after radical cystectomy in patients alive at last followup was 10.5 years (IQR 7.3, 15.3), during which time 610 had died of bladder cancer. In addition to pathological tumor stage, nodal status, multifocality and lymphovascular invasion, the patient specific factors of Charlson comorbidity index, Eastern Cooperative Oncology Group (ECOG) performance status, current smoking, preoperative hydronephrosis and receipt of adjuvant chemotherapy were significantly associated with the risk of bladder cancer death. We used cumulative scores of these variables to stratify patients into risk groups with 95%, 80%, 60%, 38% and 23% 5-year cancer specific survival from the lowest to the highest risk group, respectively (p<0.0001). The concordance index of this model was 0.75.We present a model to individualize the estimation of cancer specific survival after radical cystectomy. Pending external validation, these data may be used for patient counseling, specifically in regard to recommendations for adjuvant therapy and surveillance frequency, as well as for clinical trial development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
罗新燕发布了新的文献求助10
刚刚
Orange应助林北bei采纳,获得10
2秒前
3秒前
冷酷芝发布了新的文献求助10
6秒前
6秒前
craftsman发布了新的文献求助10
7秒前
7秒前
小李要上岸完成签到,获得积分10
7秒前
8秒前
8秒前
9秒前
chenwenjun发布了新的文献求助10
10秒前
11秒前
柚子完成签到 ,获得积分10
11秒前
12秒前
Owen应助小居居采纳,获得10
12秒前
杰jie发布了新的文献求助10
12秒前
14秒前
14秒前
1499yqq完成签到 ,获得积分10
15秒前
16秒前
安详鞋垫完成签到 ,获得积分10
17秒前
17秒前
大白发布了新的文献求助10
17秒前
科研通AI6.4应助程瑞哲采纳,获得10
19秒前
5EN完成签到,获得积分10
19秒前
superking发布了新的文献求助10
20秒前
21秒前
一颗葡萄完成签到 ,获得积分10
21秒前
小蘑菇应助爱撒娇的怜珊采纳,获得50
22秒前
22秒前
文献小白完成签到 ,获得积分10
23秒前
24秒前
快乐科研狗完成签到,获得积分10
25秒前
科研通AI6.2应助Chemistry采纳,获得10
25秒前
25秒前
吱吱吱吱完成签到 ,获得积分10
25秒前
十七发布了新的文献求助20
26秒前
乐乐应助Sam采纳,获得10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6944221
求助须知:如何正确求助?哪些是违规求助? 8629728
关于积分的说明 18305354
捐赠科研通 6379282
什么是DOI,文献DOI怎么找? 3079195
关于科研通互助平台的介绍 2120003
邀请新用户注册赠送积分活动 2056076